vanilmandelic acid has been researched along with Ganglioneuroblastoma in 4 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Ganglioneuroblastoma: A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No recurrence was observed after disappearance of tumors, and persistent tumors showed no malignant transformation or metastasis." | 1.40 | Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening. ( Aihara, T; Arakawa, A; Hanada, R; Kikuchi, A; Kishimoto, H; Koh, K; Oguma, E, 2014) |
| "Infants with neuroblastoma are known to have a better prognosis than older children." | 1.29 | Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area. ( Kurosaki, N; Miyazaki, S; Mizote, H; Ogami, H; Sera, Y; Suita, S; Takamatsu, H; Tasaka, H; Ueda, K; Zaizen, Y, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, Y | 1 |
| Sano, H | 1 |
| Kawano, A | 1 |
| Mochizuki, K | 1 |
| Takahashi, N | 1 |
| Kobayashi, S | 1 |
| Ohara, Y | 1 |
| Tasaki, K | 1 |
| Hosoya, M | 1 |
| Kikuta, A | 1 |
| Arakawa, A | 1 |
| Oguma, E | 1 |
| Aihara, T | 1 |
| Kishimoto, H | 1 |
| Kikuchi, A | 1 |
| Hanada, R | 1 |
| Koh, K | 1 |
| Suita, S | 1 |
| Zaizen, Y | 1 |
| Sera, Y | 1 |
| Takamatsu, H | 1 |
| Mizote, H | 1 |
| Ogami, H | 1 |
| Kurosaki, N | 1 |
| Ueda, K | 1 |
| Tasaka, H | 1 |
| Miyazaki, S | 1 |
| Yoneda, A | 1 |
| Oue, T | 1 |
| Imura, K | 1 |
| Inoue, M | 1 |
| Yagi, K | 1 |
| Kawa, K | 1 |
| Nishikawa, M | 1 |
| Morimoto, S | 1 |
| Nakayama, M | 1 |
4 other studies available for vanilmandelic acid and Ganglioneuroblastoma
| Article | Year |
|---|---|
Usefulness of fluorodeoxyglucose positron emission tomography/computed tomography for detection of a neuroblastic nodule in a ganglioneuroblastoma: a case report.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child, Preschool; Fluor | 2018 |
Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening.
Topics: Adrenal Gland Neoplasms; Age Factors; Child, Preschool; Female; Follow-Up Studies; Ganglioneuroblast | 2014 |
Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Ganglioneuroblastoma; Hom | 1995 |
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Chemotherapy, Adjuvant; Disease Progression; Follow-Up S | 2001 |